March 18, 2020 / 11:02 AM / 16 days ago

BRIEF-SOBI To Start A Clinical Study Related To Covid-19

March 18 (Reuters) - Swedish Orphan Biovitrum AB (publ) :

* SOBI TO INITIATE A CLINICAL STUDY TO EVALUATE WHETHER ANAKINRA AND EMAPALUMAB MAY RELIEVE COMPLICATIONS ASSOCIATED WITH SEVERE COVID-19 DISEASE

* WILL BEGIN A SHORT-TERM CLINICAL STUDY TO EVALUATE EFFICACY AND SAFETY OF ANAKINRA AND EMAPALUMAB IN TREATMENT OF HYPER-INFLAMMATORY SYNDROME, ONE OF MOST SERIOUS COMPLICATIONS ASSOCIATED WITH SEVERE COVID-19 DISEASE Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below